Page 16 - Veteran Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boehringer Ingelheim Tuesday, May 11, 2021 2:49PM IST (9:19AM GMT)   Ingelheim, Germany & New Haven, Conn., United States:   Yale University, in partnership with Boehringer Ingelheim, today announced the launch of a Biomedical Data Science Fellowship program designed to attract and support some of the brightest and most innovative minds in data science from around the world.   Post-doctoral researchers awarded a three-year fellowship will have access to Yale’s robust computational resources, biomedical data repositories and facu...

BUSINESS WIRE: Yale-Boehringer Ingelheim Biomedical Data Science Fellowship Program Seeks to Attract Top Researchers from Around the World 10.05.2021 - 14:00 | Quelle: Business_Wire | Lesedauer etwa 5 min. | Text vorlesen Stop Pause Fortsetzen facebook twitter NEW HAVEN, Conn. & INGELHEIM, Germany (BUSINESS WIRE) 10.05.2021 Yale University, in partnership with Boehringer Ingelheim, today announced the launch of a Biomedical Data Science Fellowship program designed to attract and support some of the brightest and most innov...

VAntage Point VA genetics program aims to increase mental health treatments for Veterans VA’s Million Veteran Program, one of the world’s largest databases of health and genetic information, has published influential papers on genetic risk for a number of mental health conditions, including PTSD, anxiety, and substance use disorders. Some mental illnesses, such as opioid use disorder, schizophrenia, and bipolar disorder, have not been as well-represented among MVP volunteers. Leaders of the Million Veteran Program (MVP) are addressing this gap through a new initiative called MVP MIND. It ...

Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify existing drugs, either FDA-approved or in clinical development for other conditions, that can be repurposed for the early management of COVID-19. Doing so, they say, will help keep people with the virus from being hospitalized. IFNAR2 is the target for approved drugs often used by patients with relapsing forms of the central nervous system disorder multiple sclerosis. The researchers believe the most promising ACE2 therapy against COVID...

DBusiness Magazine DBusiness Daily Update: Southfield’s HED Merges with California Architectural Firm, Better Made Snack Foods CEO Sam Cipriano Dies, and More Our roundup of the latest news from metro Detroit and Michigan businesses as well as announcements from government agencies, including updates about the COVID-19 pandemic. To share a business or nonprofit story, please send us a message. Courtesy of Bridge, as of April 13 Our roundup of the latest news from metro Detroit and Michigan businesses as well as announcements from government agencies, including updates about the COVID-19 ...